Nature Communications (Oct 2023)

2-Oxabicyclo[2.2.2]octane as a new bioisostere of the phenyl ring

  • Vadym V. Levterov,
  • Yaroslav Panasiuk,
  • Kateryna Sahun,
  • Oleksandr Stashkevych,
  • Valentyn Badlo,
  • Oleh Shablykin,
  • Iryna Sadkova,
  • Lina Bortnichuk,
  • Oleksii Klymenko-Ulianov,
  • Yuliia Holota,
  • Leonid Lachmann,
  • Petro Borysko,
  • Kateryna Horbatok,
  • Iryna Bodenchuk,
  • Yuliia Bas,
  • Dmytro Dudenko,
  • Pavel K. Mykhailiuk

DOI
https://doi.org/10.1038/s41467-023-41298-3
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 10

Abstract

Read online

Abstract The phenyl ring is a basic structural element in chemistry. Here, we show the design, synthesis, and validation of its new saturated bioisostere with improved physicochemical properties − 2-oxabicyclo[2.2.2]octane. The design of the structure is based on the analysis of the advantages and disadvantages of the previously used bioisosteres: bicyclo[1.1.1]pentane, bicyclo[2.2.2]octane, and cubane. The key synthesis step is the iodocyclization of cyclohexane-containing alkenyl alcohols with molecular iodine in acetonitrile. 2-Oxabicyclo[2.2.2]octane core is incorporated into the structure of Imatinib and Vorinostat (SAHA) drugs instead of the phenyl ring. In Imatinib, such replacement leads to improvement of physicochemical properties: increased water solubility, enhanced metabolic stability, and reduced lipophilicity. In Vorinostat, such replacement results in a new bioactive analog of the drug. This study enhances the repertoire of available saturated bioisosteres of (hetero)aromatic rings for the use in drug discovery projects.